Scinovex
review Open AccessTop 1% cited

Executive Summary: Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America

Clinical Infectious Diseases · 2016 · Vol. 62(4) · pp. 409–417
Peter G. PappasCarol A. KauffmanDavid R. AndesCornelius J. ClancyKieren A. MarrLuis Ostrosky‐ZeichnerAnnette C. ReboliMindy G. SchusterJosé A. VázquezThomas J. WalshTheoklis E. ZaoutisJack D. Sobel

Abstract

It is important to realize that guidelines cannot always account for individual variation among patients. They are not intended to supplant physician judgment with respect to particular patients or special clinical situations. IDSA considers adherence to these guidelines to be voluntary, with the ultimate determination regarding their application to be made by the physician in the light of each patient's individual circumstances.

Antifungal resistance and susceptibilityPneumocystis jirovecii pneumonia detection and treatmentNeutropenia and Cancer InfectionsMedicineGuidelineExecutive summaryClinical PracticeFamily medicineIntensive care medicinePathology

MeSH terms

CandidiasisHumansPractice Guidelines as Topic
Citations
1,277
FWCI
178.43
field-weighted impact
References
2
Percentile
100%
vs. same field & year
Citations per year
Citation Network

How this paper connects to the literature. Drag to explore, click any node to open that paper.